XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense (benefit) [Table Text Block]
    December 31, 2022     January 1, 2022     January 2, 2021  
    $     $     $  
Loss from continuing operations before income taxes   (11,858 )   (7,600 )   (50,042 )
Canadian statutory rate   26.5%     26.5%     26.5%  
Income tax benefit at statutory rate   (3,142 )   (2,014 )   (13,261 )
Stock-based compensation   978     (4,796 )   2,159  
Disallowed executive compensation   374     138     2,801  
Foreign tax rate differential   76     (31 )   (105 )
Excess tax benefits related to stock-based compensation                  
Change in valuation allowance   (471 )   975     560  
Change in enacted tax rates   (340 )   (442 )   250  
CARES Act   -     -     2,472  
Change in valuation of state deferred tax assets   -     -     (3,900 )
Other   185     (258 )   1,374  
Income tax benefit   (2,340 )   (6,428 )   (7,650 )
    December 31, 2022     January 1, 2022     January 2, 2021  
    $     $     $  
Canada   (11,181 )   (10,797 )   (14,700 )
U.S.   (2,506 )   3,855     (34,521 )
Other   1,829     (658 )   (821 )
Loss from continuing operations before income taxes   (11,858 )   (7,600 )   (50,042 )
    December 31, 2022     January 1, 2022     January 2, 2021  
    $     $     $  
Current income tax expense (benefit):                  
Canada   84     (9 )   (154 )
U.S.   (55 )   (75 )   (14,148 )
Other   2,438     (359 )   589  
    2,467     (443 )   (13,713 )
                   
Deferred income tax expense (benefit):                  
Canada   -     299     (291 )
U.S.   (4,672 )   (6,129 )   5,532  
Other   (135 )   (155 )   822  
    (4,807 )   (5,985 )   6,063  
Income tax benefit   (2,340 )   (6,428 )   (7,650 )
Schedule of deferred tax assets and liabilities [Table Text Block]
    December 31, 2022     January 1, 2022  
    $     $  
Differences in property, plant and equipment and intangible assets   (28,088 )   (54,761 )
Capital and non-capital losses   17,335     26,751  
Interest expense limitation (163j)   9,464     13,064  
Tax benefit of scientific research expenditures   2,866     2,744  
Stock-based compensation   2,160     680  
Inventory basis differences   1,805     1,148  
Right-of-use lease assets   (23,071 )   (13,224 )
Lease liabilities   23,609     13,346  
Other accrued reserves   2,458     1,468  
    8,538     (8,784 )
Less: valuation allowance   4,826     5,267  
Deferred income tax asset (liability)   3,712     (14,051 )
Schedule of deferred tax assets and liabilities by geographic segment [Table Text Block]
    December 31, 2022     January 1, 2022  
    $     $  
Canada   (325 )   (325 )
U.S.   3,978     (13,649 )
Other   59     (77 )
Deferred income tax asset (liability)   3,712     (14,051 )
Schedule of deferred income tax valuation allowance [Table Text Block]
    December 31, 2022     January 1, 2022  
    $     $  
Balance, beginning of year   5,267     4,284  
Increase (decrease) in valuation allowance   (441 )   983  
Balance, end of year   4,826     5,267